Astrana Health FY2024 EPS Forecast Lowered by William Blair

Astrana Health, Inc. (NASDAQ:ASTH) – Stock analysts at William Blair reduced their FY2024 EPS estimates for shares of Astrana Health in a research report issued on Thursday, November 7th. William Blair analyst R. Daniels now expects that the company will post earnings of $1.10 per share for the year, down from their previous estimate of $1.18. The consensus estimate for Astrana Health’s current full-year earnings is $1.31 per share. William Blair also issued estimates for Astrana Health’s Q2 2025 earnings at $0.30 EPS, Q3 2025 earnings at $0.34 EPS and FY2025 earnings at $1.24 EPS.

A number of other analysts have also recently commented on ASTH. Truist Financial upped their price objective on shares of Astrana Health from $50.00 to $59.00 and gave the company a “buy” rating in a research report on Friday, August 9th. Stifel Nicolaus upped their price objective on shares of Astrana Health from $48.00 to $60.00 and gave the company a “buy” rating in a research report on Thursday, August 1st. BTIG Research upped their price objective on shares of Astrana Health from $60.00 to $70.00 and gave the company a “buy” rating in a research report on Thursday, October 3rd. TD Cowen started coverage on shares of Astrana Health in a research report on Monday, October 14th. They issued a “buy” rating and a $66.00 price objective for the company. Finally, Robert W. Baird upped their price objective on shares of Astrana Health from $54.00 to $67.00 and gave the company an “outperform” rating in a research report on Thursday, August 15th. One analyst has rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Buy” and an average price target of $62.00.

Astrana Health Stock Performance

Shares of Astrana Health stock opened at $42.91 on Monday. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.84 and a current ratio of 1.84. Astrana Health has a 52 week low of $29.63 and a 52 week high of $63.20. The firm has a fifty day moving average of $55.40 and a two-hundred day moving average of $47.72. The stock has a market capitalization of $2.11 billion, a price-to-earnings ratio of 33.01, a PEG ratio of 1.79 and a beta of 1.24.

Astrana Health (NASDAQ:ASTH) last issued its earnings results on Thursday, November 7th. The company reported $0.33 EPS for the quarter, meeting the consensus estimate of $0.33. The company had revenue of $478.71 million during the quarter, compared to analysts’ expectations of $462.01 million. Astrana Health had a net margin of 3.63% and a return on equity of 9.57%. During the same quarter in the previous year, the company posted $0.47 EPS.

Hedge Funds Weigh In On Astrana Health

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Diamond Hill Capital Management Inc. acquired a new position in Astrana Health in the 3rd quarter worth $8,245,000. Summit Global Investments acquired a new position in shares of Astrana Health during the 3rd quarter worth about $753,000. Louisiana State Employees Retirement System acquired a new position in shares of Astrana Health during the 3rd quarter worth about $1,165,000. F M Investments LLC acquired a new position in shares of Astrana Health during the 3rd quarter worth about $11,738,000. Finally, SteelPeak Wealth LLC acquired a new position in shares of Astrana Health during the 3rd quarter worth about $39,398,000. 52.77% of the stock is owned by institutional investors and hedge funds.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.